XML 51 R13.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Note D - Stock Based Compensation | 9 Months Ended
--- | ---
Sep. 30, 2013
Disclosure Text Block Supplement [Abstract] |
Compensation and Employee Benefit Plans [Text Block] | NOTE D: STOCK BASED COMPENSATION The Company maintains a stock option plan under which incentive stock options and nonqualified stock options may be granted. On March 2, 2006, the Company’s Board of Directors (the “Board”) adopted, and shareholders later approved, the 2006 Stock Option Plan (the “2006 Plan”). Under the 2006 Plan 750,000 shares are reserved for the issuance of stock options to directors, officers, key employees, and others. The option exercise price under the 2006 Plan is the fair market value of the stock on the date the option is granted. The fair market value is determined by the average of the highest and lowest sales prices for a share of the Company’s common stock, on its primary exchange, on the same date that the option is granted. Outstanding nonqualified stock options at September 30, 2013, must be exercised within either five or ten years from the date of grant. There were no incentive stock options outstanding at September 30, 2013. During the first nine months of 2013, options for 35,000 shares were issued under the 2006 Plan at a per-share option exercise price of $10.44. As of September 30, 2013, 366,000 options were available for future grants. The total grant date fair value of options vested during the first nine months of 2013 was approximately $180,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the third quarter of 2013 was approximately $39,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the first nine months of 2013 was approximately $315,000 and includes approximately $180,000 recognized as a result of the increased annual grant of 5,000 shares to each non-employee director during the first nine months of 2013. The recognition of stock-based compensation expense did not have a recognizable impact on diluted or basic earnings per share reported for the third quarter ending September 30, 2013 but did decrease diluted and basic earnings per common share by approximately $0.02 and $0.03, respectively, during the nine months ending September 30, 2013. As of September 30, 2013, the Company had stock-based compensation plans with total unvested stock-based compensation expense of approximately $419,000 which is being amortized on a straight-line basis over the remaining vesting period. As a result, the Company expects to recognize approximately $33,000 in additional compensation expense related to unvested option awards during the remainder of 2013 and to recognize approximately $134,000 in additional compensation expense related to unvested option awards during 2014, $131,000 in additional compensation expense related to unvested option awards during 2015, $91,000 in additional compensation expense related to unvested option awards during 2016, and $30,000 in additional compensation expense related to unvested option awards during 2017. The total grant date fair value of options vested during the first nine months of 2012 was approximately $204,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the third quarter of 2012 was approximately $49,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the first nine months of 2012 was approximately $303,000 and includes approximately $199,000 recognized as a result of the increased annual grant of 5,000 shares to each non-employee director during the first nine months of 2012. The recognition of stock-based compensation expense did not have a recognizable impact on diluted or basic earnings per share reported for the third quarter ending September 30, 2012 but did decrease diluted and basic earnings per common share by approximately $0.02 during the nine months ending September 30, 2012. As of September 30, 2012, the Company had stock-based compensation plans with total unvested stock-based compensation expense of approximately $798,000 which was being amortized on a straight-line basis over the remaining vesting period. The weighted average grant date fair value of options granted during the first nine months of 2013 and 2012 was $5.13 per share and $5.96 per share, respectively. The fair value of the Company’s employee stock options was estimated at the date of grant using a Black-Scholes-Merton (“BSM”) option-pricing model using the following assumptions:
|  | Nine Months Ended September 30,
|  | 2013 |  |  | 2012
Dividend yield |  |  | 0% |  |  |  | 0 | %
Volatility |  |  | 62.69% |  |  | 57.88% | - | 65.89%
Risk-free rate |  |  | 0.61% |  |  | 0.64% | - | 1.09%
Expected life (in years) |  |  | 4.3 |  |  | 4.2 | - | 6.5
Fair value of options |  |  | $5.13 |  |  | $5.54 | - | 6.06
The Company does not anticipate paying any additional cash dividends in the foreseeable future other than those dividends paid in 2012. The estimated volatility is based on the historical volatility of our stock. The risk free rate for the periods within the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The expected life of the options was calculated based on the historical exercise behavior. Information related to option activity for the nine months ended September 30, 2013 is as follows:
|  | Shares Under Options |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Term |  |  | Aggregate Intrinsic Value* |
|  |  |  |  |  | (per share) |  |  | (in years) |  |  |  |  |
Outstanding-beginning of year |  |  | 235,379 |  |  | $ | 11.38 |  |  |  |  |  |  |  |  |
Granted |  |  | 35,000 |  |  |  | 10.44 |  |  |  |  |  |  |  |  |
Exercised |  |  | (1,790 | ) |  |  | 10.44 |  |  |  |  |  |  |  |  |
Cancelled/forfeited/expired |  |  | (99,024 | ) |  |  | 11.71 |  |  |  |  |  |  |  |  |
Outstanding at September 30, 2013 |  |  | 169,565 |  |  | $ | 11.00 |  |  |  | 6.17 |  |  | $ | 1,101,000 |
Exercisable at September 30, 2013 |  |  | 96,026 |  |  | $ | 11.01 |  |  |  | 4.54 |  |  | $ | 622,519 |
___________________________ |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
* The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option. The per share market value of our common stock, as determined by the closing price on September 30, 2013, was $17.49. |
The number, weighted average exercise price and weighted average remaining contractual life of options outstanding as of September 30, 2013 and the number and weighted average exercise price of options exercisable as of September 30, 2013 are as follows:
Exercise Price |  |  | Shares Under Outstanding Options |  |  | Weighted-Average Remaining Contractual Term |  |  | Shares Under Exercisable Options |
|  |  |  |  |  | (in years) |  |  |  |
$3.84 |  |  | 4,000 |  |  | 0.4 |  |  | 4,000 |
$10.44 |  |  | 25,000 |  |  | 4.4 |  |  | 25,000 |
$10.90 |  |  | 15,000 |  |  | 3.7 |  |  | 15,000 |
$10.90 |  |  | 69,000 |  |  | 8.7 |  |  | 13,800 |
$11.22 |  |  | 30,565 |  |  | 7.2 |  |  | 12,226 |
$11.54 |  |  | 8,000 |  |  | 3.4 |  |  | 8,000 |
$11.75 |  |  | 8,000 |  |  | 2.4 |  |  | 8,000 |
$14.32 |  |  | 10,000 |  |  | 1.4 |  |  | 10,000 |
|  |  | 169,565 |  |  | 6.2 |  |  | 96,026 |
Cash received from option exercises totaled approximately $19,000 and $55,000 during the nine months ended September 30, 2013 and September 30, 2012, respectively. The Company issues new shares upon option exercise.

X
- Definition The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans. + References No definition available. + Details
Name: | us-gaap_CompensationAndEmployeeBenefitPlansTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_DisclosureTextBlockSupplementAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration